Gram-positive bacterial infection
Drug research and approvals for gram-positive bacterial infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 22, 2026, 280 studies of gram-positive bacterial infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 280
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- A Clinical Trial to Improve Treatment Outcomes Among Persons With Drug Sensitive Pulmonary TB Treated With 4 or 6…NCT07947056 · Phase 3 · Tuberculosis Research Centre, India · starts Jun 6, 2026
- Factors Associated With Positive Post-Treatment STI Tests and Sexual Knowledge, Attitudes, Behaviors and PracticesNCT07936214 · Not applicable · Centre Hospitalier de Martigues · starts Oct 29, 2026
- Clinical Characteristics, Treatment, Diagnostic Findings, and Outcomes of Tuberculous Meningitis in Indonesia, 2022-2025NCT07929519 · Not reported · Ina-Respond · starts Sep 24, 2026
- EFFECTIVENESS OF A SCHOOL-CENTRED PRIMARY AND SECONDARY PREVENTION PROGRAM ON PREVALENCE OF LATENT RHEUMATIC HEART…NCT07927868 · Not reported · Centre for Infectious Disease Research in Zambia · starts Jan 14, 2025
- Biomarker Analysis for Diagnosing and Treatment Monitoring in Extrapulmonary Tuberculosis Patients in Nairobi, KenyaNCT07901387 · Not reported · Nagasaki University · starts Apr 8, 2025
- A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For…NCT07894055 · Phase 2 · Changchun BCHT Biotechnology Co. · starts Aug 12, 2026
- BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in ChildrenNCT07893444 · Phase 2 · Huashan Hospital · starts Jul 8, 2026
- A Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in…NCT07891728 · Not reported · SalivIQ Diagnostics, Inc. · starts Oct 9, 2026
- A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated…NCT07891104 · Phase 1 / Phase 2 · Institute of Medical Biology, Chinese Academy of Medical Sciences · starts Oct 11, 2026
How its trials ended
44 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 14 whose ending is known, 36% met their primary endpoint, 7% missed it and 57% stopped early.
- Completed, result not reported2045%
- Met its primary endpoint511%
- Ongoing511%
- Status unknown511%
- Stopped: other or unclear49%
- Stopped: enrollment or feasibility25%
- Stopped: sponsor or business decision25%
- Missed its primary endpoint12%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA